Sana Biotechnology SANA Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's total liabilities & equity?
- Sana Biotechnology (SANA) reported total liabilities & equity of $373.59M in Q1 2026.
- How has Sana Biotechnology's total liabilities & equity changed year-over-year?
- Sana Biotechnology's total liabilities & equity decreased by 16.1% year-over-year, from $445.47M to $373.59M.
- What is the long-term trend for Sana Biotechnology's total liabilities & equity?
- Over 5 years (2020 to 2025), Sana Biotechnology's total liabilities & equity has grown at a -10.6% compound annual growth rate (CAGR), from $730.3M to $416.89M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.